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Background: In several recent papers it has been suggested that HIV prevalence and incidence are
declining in Zimbabwe as a result of changing sexual behavior. We provide further support for these
suggestions, based on an analysis of more extensive, age-stratiﬁed, HIV prevalence data from 1990 to 2009 for
perinatal women in Harare, as well as data on incidence and mortality.
Methodology/principal ﬁndings: Pooled prevalence, incidence and mortality were ﬁtted using a simple
susceptible-infected (SI) model of HIV transmission; age-stratiﬁed prevalence data were ﬁtted using double-
logistic functions. We estimate that incidence peaked at 5.5% per year in 1991 declining to 1% per year in 2010.
Prevalence peaked in 1998/9 [35.9% (CI95: 31.3–40.7)] and decreased by 67% to 11.9% (CI95: 10.1–13.8) in 2009.
For women b20 y, 20–24 y, 25–29 y, 30–34 y and ≥35 y, prevalence peaked at 25.4%, 34.2%, 47.1%, 44.0% and
33.5% in 1993, 1996, 1997, 1998 and 1999, respectively, declining thereafter in every age group. Among women
b25 y, prevalence peaked in 1994 at 28.8% declining thereafter by 69% to 8.9% (CI95: 6.8–11.5) in 2009.
Conclusion/signiﬁcance:HIV prevalence declined substantially among perinatal women in Harare after 1998
consequent upon a decline in incidence starting in the early 1990s. Our model suggests that this was primarily a
result of changes in behavior which we attribute to a general increase in awareness of the dangers of AIDS and
the ever more apparent increases in mortality.
© 2011 Elsevier B.V. All rights reserved.Introduction
Zimbabwe is at the center of the HIV pandemic: 1.2 million of its
12 million people are infected with HIV (UNAIDS, 2010). However,
several recent reports indicate that HIV prevalence is declining rapidly.
In the Eastern highlands of Zimbabwe, between 1998 and 2003,HIV and AIDS Conference: taking
June 2004, and at the UNAIDS/
s in HIV prevalence and incidence
, 15–17th November 2004.
orrowdale Road, Borrowdale,
mphrey).
South Africa.
ndation, Harare, Zimbabwe.
watersrand Medical School,
ll rights reserved.prevalence declined by 12% among all reproductive-aged women and
by 49% among those aged 17–29 years; moreover these declines were
linked to sexual behavioral change (Gregson et al., 2006). Among
women attending antenatal sentinel surveillance sites throughout the
country, HIV-1prevalence declined by one-half between 1999 and 2009
(Gregson et al., 2010; Mahomva et al., 2006; MOH, 2009a). Similarly, in
the ZVITAMBO trial a study of 14,110 postpartumwomen enrolled from
maternity hospitals in Greater Harare between November 1997 and
January 2000, the monthly prevalence increased from 28.5% (CI95:
23.9–33.4) in December 1997 to 35.9% (CI95: 31.3–40.7) in December
1998 and then declined to 29.5% (CI95: 25.2–34.0) in December 1999
(p=0.002 and 0.003 for linear and quadratic terms, respectively)
(Humphrey et al., 2007). These changes remained statistically signiﬁ-
cant after adjustment for a number of independent factors suggesting
that the ZVITAMBO trial had spanned the peak of the epidemic among
perinatal women in Harare.
Several modeling studies have led to suggestions that HIV incidence
in Zimbabwe peaked around 1990 (Lopman and Gregson, 2008), and
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89J.W. Hargrove et al. / Epidemics 3 (2011) 88–94that at least part of the decline in HIV incidence could be ascribed
to changing sexual behavior (Gregson et al., 2010; Hallet et al., 2009;
Hallett et al., 2006).
This paper complements and extends these ﬁndings by presenting
an analysis of HIV prevalence, incidence and mortality data collected
between 1990 and 2009 from 22,684 perinatal women in Greater
Harare.
Methods
Sources of data
Prevalence data were drawn from nine data sets (Table 1) from
public sector antenatal sites located in high-density urban neighbor-
hoods ofGreater Harare. The three sites included in the1990 studywere
all part of the 1994/5 study, and the four sites included in the 1994/5
studywere all included in ZVITAMBO. One of two ZimbabweMinistry of
Health and Child Welfare (MoHCW) sentinel sites included in the
national surveys in 1999–2009 had also been a site in the ZVITAMBO
Trial, though neither had been included in the earlier studies (further
details of this trial provided in the Supplementary Information).
The HIV sentinel surveys in antenatal clinic sites were conducted by
theMoHCW in 1999/2000, 2001, 2002, 2004, 2006 and 2009 (Mahomva
et al., 2006; MOH, 2007, 2009b). All women presenting for antenatal
care at designated sentinel surveillance sites during the recruitment
periods for each of the six surveys were eligible for inclusion. Data for
two of these sites, which are located in Greater Harare and were
included in all four surveys, were extracted for the current analysis.
Women were tested for HIV by ELISA on an unlinked and anonymous
basis.
Incidence data were available for a cohort of 372 HIV-negative
antenatalwomenwhowere enrolled in anobservational study between
September 1991 and January 1993 and were followed for 24 months
postpartum (Mbizvo et al., 2004), and among 9562 women enrolled in
ZVITAMBO between October 1997 and January 2000 who were HIV-
negative at delivery andwere followed for 12 to 24 months postpartum
(Humphrey et al., 2006a). Mortality data were obtained from records
provided by the City of Harare (Harare City Health Department, 2004).
Condomdistribution and saleswere extracted frompublished reports of
the Zimbabwe National Family Planning Council (PSI, 2004), and
program records of Population Services International.
Modeling
HIV status, age, and date of testing were extracted from the nine
databases and merged; the combined database included 22,684
women who provided unequivocal HIV test results. HIV prevalence
in each of the databases analyzedwas estimated for women of all ages
pooled, and for age-stratiﬁed data.
We use a standard susceptible-infected (SI) model which we ﬁt to
data on HIV prevalence, incidence and mortality, all pooled on age. We
let S(t) and I(t) be the number of susceptible and infected adults over
the age of 25 years at time t, with N(t)=S(t)+ I(t). Adults enter the
population at risk at a rate b times the population 15 years earlier so
that the total population growth rate matches the reported value. To
allow for heterogeneity in sexual behavior and to ﬁt the observed
asymptotic prevalence of infection the transmission parameter takes
the value λ0 at the start of the epidemic and declines exponentially at
rate α times the prevalence of infection. The background death rate is μ.
We use a Weibull survivorship,W(t), with a median of 9.8 years and a
shape parameter of 2.25 to capture the dependence of HIV-related
mortality on time since infection. The model is then
dS
dt
= bN t−25ð Þ−λ0e−αI =NSI=N−μS ð1Þ
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Fig. 1. Mortality (M) in Harare as a function of calendar year (t). The dots indicate the
raw data. The data for 1981–1988were ﬁtted by the exponential functionM=1+4.956
exp(−0.147(t−1981)) where exp indicates the exponential function. Subtracting the
functional values from the raw data for each year provides an estimate of the mortality
due to AIDS (open circles).
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dt
= λ0e
−αI=NSI=N−μ I−D ð2Þ
D = λ0e
−αI=NSI=N
 
⊗W ð3Þ
where⊗ indicates convolution and D is number of HIV-related deaths
per unit time. In order to explore the possibility that the decline in
prevalence is due to changes in behavior resulting from increased
awareness of the epidemic or behaviour change programs, replace λ0
in Eqs. (1) to (3) by, λ0(t), a logistic function decreasing at a rate α,
reaching half-height at time τ and converging to an asymptotic value
of b so that
λ0 tð Þ = λ0 1−bð Þ
eα t−τð Þ
1þeα t−τð Þ + b
( )
: ð4Þ
We then adjust b, α and τ to ﬁt the data. To explore the possibility
that the decline in prevalence is due to changes in behavior arising
from peoples' increased awareness of deaths in the population we
replace λ0 in Eqs. (1) to (3) by λ0(D/N), an exponential function
decreasing at a rate ε as the mortality D/N increases, so that
λ0 D=Nð Þ = λ0e−εD=N ð5Þ
We then adjust ε to ﬁt the data. In all cases we carry out a weighted
least squares ﬁt jointly to the incidence, prevalence and mortality
data.
Statistical methods
Wedid not have sufﬁcient information on age-speciﬁc fertility, as a
function of time, to construct such a model for the age-stratiﬁed data,
which were accordingly ﬁtted using a double-logistic function:
P tð Þ = e
α t−τð Þ
1+eα t−τð Þ
2a
e−β t−τð Þ
1+e−β t−τð Þ
+ b
" #
ð6Þ
where α is the initial rate of increase in prevalence to a peak level
proportional to a, and where prevalence converges, at rate β, to b≥0
for large t; τ is an offset parameter which determines the timing of the
peak in prevalence. This model was ﬁtted to prevalence calculated
separately for ﬁve age categories: b20, 20–24, 25–29, 30–34, and
≥35 years: it was a statistical ﬁt aimed simply at estimating the
underlying prevalence trends in the age-speciﬁc data and serving as a
check on the results emerging from the ﬁt to the age-pooled data. All
analyses were performed using Stata (Stata, College Station, Texas,
USA), SAS (SAS Institute Inc., Cary, North Carolina, USA) andMicrosoft
Excel.
Mortality rates in Harare
Death certiﬁcates in Zimbabwe do not generally record HIV as a
cause of death. To estimate the mortality from causes other than AIDS
we ﬁtted an exponential function to the declining mortality between
1981 and 1988, before there were signiﬁcant numbers of deaths
attributable to HIV, assuming an asymptotic mortality value of 1 per
thousand. We then extrapolate this background mortality for the
period after 1998 and subtract it from the total mortality to estimate
the mortality attributable to HIV-AIDS over this period.Results
Estimated mortality due to HIV
Following the end of the liberation war in 1980, international
relations were normalized in Zimbabwe and there was a sharp inﬂow
of international aid; there was also a marked, steady decline in
mortality until 1988. Thereafter, in line with the appearance of the
ﬁrst AIDS cases in the late 1980s, total mortality increased by a factor
of six by the end of the 1990s, and began to decline again in 2003
(Fig. 1).
We cannot be certain that non-AIDS mortality would have
continued to decrease after 1988 in the manner predicted in Fig. 1.
Nonetheless, the difference between the very high mortality at the
end of the 1990s, overwhelmingly attributable to HIV-AIDS, and low
levels in the middle 1980s, before the epidemic took hold, suggests
that the assumed patterns of change in the background mortality
provide a good approximation to the true situation.
Similarly, while the available mortality data was not stratiﬁed by
gender it seems likely that the pattern of death in males and females
was similar so that Fig. 1 gives a reasonable estimate of trends in HIV
mortality among adult women, though not the absolute levels.
HIV-1 prevalence and incidence pooled on age
The prevalence of HIV increased from close to zero in the early 1980s
(Blair Research Institute OU, 1996) to 35.9% (95% CI: 31.3–40.7) in
December 1998, and thendecreased by about 10%per year to 11.9% (95%
CI: 10.1–13.8) in 2009 (Fig. 2). AIDS-related mortality began to increase
in the late 1980s and peaked in 2001/2002. The data on incidence of HIV
in Harare are limited andwe have only two point estimates: 4.8% (CI95:
3.1–6.5) per year among pregnant women recruited in 1990/1 (Mbizvo
et al., 2004), and 3.4% (CI95: 3.0–3.8) among post partum women
recruited to the ZVITAMBO study in 1998/9 (Humphrey et al., 2006a).
Fitting the dynamical model to the pooled data we ﬁnd that, if no
assumption is made about a decline in HIV incidence, prevalence
stabilizes at 27%, the level dictated by the balance between the
accumulation of new infections and losses due to AIDS deaths (dashed
lines in Fig. 2A) and clearly fails to ﬁt the prevalence data after the year
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Fig. 2. HIV prevalence (blue), incidence (red) and mortality (black) among women attending maternity clinics in Harare and Chitungwiza. Dots show observed values: incidence
from follow-up of cohorts of pregnant (Mbizvo et al., 2004) and post partumwomen (Humphrey et al., 2006a). Lines show the ﬁtted prevalence, incidence andmortality. The models
allow for reductions in transmission as a result of behavior change (A) or in response to mortality (B) as described in the text. Lines show results of ﬁtting model. The best ﬁts under
the assumption of no change in behavior is indicated by the dashed lines in (A).
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Fig. 3. The age structure among mothers attending maternity clinics in Harare and
Chitungwiza, 1991–2009. Sources of data: 1990 — HIV-1 prevalence survey among
antenatal women (Fabiani et al., 2001), n=1008; 1994/95 — HIV-1 and HIV-2
prevalence survey among antenatal women in Harare in 1994/95 (Zaba et al., 2003),
n=1168; 1998 — women enrolled in ZVITAMBO from November 1997–December
1998 (Humphrey et al., 2007), n=7253; 1999 — women enrolled in ZVITAMBO from
January 1999–January 2000, n=6857; 2000, 2001, 2002, 2004, 2006 and 2009 —
women enrolled in the Harare sites of the Zimbabwe Ministry of Health and Child
Welfare sentinel survey (Mahomva et al., 2006) conducted in each of these years,
n=841, 1043, 1097, 1118, 1115 and 1237, respectively.
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education about HIV resulted in increasing awareness of the epidemic,
which led to a reduction in risky sexual behavior as described by Eq. (4).
The best ﬁt (solid lines in Fig. 2A) is achieved if we assume that changes
in behavior reduced the risk of infection by about 93% between the late
1980s and the early 1990s. We also investigated an alternative
explanation that the change in behavior and corresponding decline in
incidence, resulted from peoples' response to observed mortality using
Eq. (5). In this case the best ﬁt suggests that transmission must have
fallen by 30% for each 1% increase in mortality (Fig. 2B). There is,
however, a delay between changes in incidence and changes in
mortality. Changes in behavior, and hence incidence, in response to
mortality therefore lead to oscillations in the epidemic curves (Fig. 2B).
This model, on its own, does not provide a satisfactory ﬁt to the later
prevalence data but we cannot, and do not, rule out the possibility that
both factors contributed to the decline in prevalence to some degree.
Age structure of perinatal attendees, 1990 to 2009
The proportion of perinatal attendees less than 20 years old
increased from 10.5% in 1990 to 23.0% in 2002, declining thereafter to
12.7% in2009 (Fig. 3;ﬁlled circles); over the sameperiods theproportion
ofmothers≥35 years fell from13% to 3.6% in 2002, increasing to 6.0% by
2009 (Fig. 3; open diamonds). Changing age structure could have
resulted from older women experiencing proportionately greater HIV-
associated death, reduced fertility, reduced family size, and/or emigra-
tion (Terceira et al., 2003). Regardless of the cause, the temporary shift
to a younger age distribution among perinatal attendees would have
resulted in a decline in the overall HIV prevalence, even if HIV incidence
was unchanged, since prevalence increases rapidly between the ages of
16 and 30 years (Humphrey et al., 2007). Further analyses accordingly
accounted for maternal age.
Age-speciﬁc HIV-1 prevalence and incidence
Age-speciﬁc prevalence peaked in all age groups between 1990
and 1999 and has since declined signiﬁcantly (Pb0.001) by N65%
among all women b35 years old (Fig. 4; Table S1, Supplementary
Information). The decline in prevalence seen in Fig. 1 is not thus anartifact of age-pooling. Prevalence peaked progressively later, and at
higher levels, with increasing age up to 30 years. For women b20 y,
20–24 y, 25–29 y, 30–34 y and ≥35 y, peak prevalences estimated
from separate age group analyses were 25.4%, 34.2%, 47.1%, 44.0% and
33.5% and occurred in about 1993, 1996, 1997, 1998 and 1999,
respectively.
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Fig. 4. Time trends in HIV-1 prevalence, stratiﬁed by age, among women attending maternity clinics in Greater Harare, Zimbabwe. The data were ﬁtted using a double logistic
function. For the ZVITAMBO trial data were pooled for November 1997 to June 1998, July to December 1998, January to June 1999 and July 1999 to January 2000. Parameter estimates,
with 95% conﬁdence intervals, for the optimal ﬁt of the model are provided in Table S1 of the Supplementary Materials.
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Fig. 5. Red line: Estimated incidence of HIV for women attending antenatal clinics (from
the model results in Fig. 2). Purple dots: HIV-1 prevalence in women b20 years old
(from Fig. 4) scaled vertically to match the area under the incidence curve and shifted
down by two years. Red dots: HIV incidence from follow-up of cohorts of pregnant
(Mbizvo et al., 2004) and post partum women (Humphrey et al., 2006a) (see Fig. 2).
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reﬂect recent HIV-1 infections and are therefore good indicators of
trends in incidence (Gregson et al., 2002; Kilian et al., 1999; Shelton et
al., 2006; Zaba et al., 2000). Among women b24 years old, prevalence
increased between 1991 and 1994 by 52%, from 18.9% (15.2–23.0) in
1991 to 28.8 (25.0–32.9) in 1994, then declined by 67% to 8.9% (CI95:
6.8–11.5) between 1994 and 2009. An explanation that is consistent
with these observed changes in prevalence, is that incidence among
young women continuously increased up to the early 1990s and then
substantially and continuously declined thereafter (Williams et al.,
2003).
The importance of the age-stratiﬁed analysis is that it applies to
fuller data than are available for HIV-prevalence changes in Zimbabwe
as a whole. The age stratiﬁed data for young women make it clearer
than it is possible to see from any other data set that incidence has
been in decline since 1993. The ﬁts to the age-stratiﬁed data thus
support both the timing of the onset of the decline in incidence, and
the magnitude suggested by the model ﬁtted to the age-pooled data
(Fig. 2). To emphasize this point, in Fig. 5 we compare the modeled
incidence with the HIV-1 prevalence in women of the youngest age-
class (Fig. 4), normalized to match the area under the estimated
incidence curve (Fig. 2) and shifted back in time by two years. The
scaled incidence and shifted prevalence matches the estimated
incidence quite precisely.
The shift stems from the fact that current prevalence reﬂects
incidence averaged over the time exposed to HIV. The lowest age-
group includes women 15 to 19 years of age, but with very few ﬁfteen
year olds, so that the range of ages during which these women have
been exposed to HIV is four years and the average time since infection
must be about two years. This in itself is an important ﬁnding since if
age-speciﬁc prevalence curves for teenage pregnant women are to be
used as a surrogate for time-trends in incidence they need to beshifted down by about two years. The fact that age-speciﬁc trends in
HIV-prevalence in young women, which are available for many
countries, can be used to determine historical trends in HIV incidence
is of great importance.Discussion
This paper introduces novel approaches to modeling HIV in Africa.
For the ﬁrst time, we have ﬁtted a compartmental model simulta-
neously to data on HIV-1 prevalence, incidence and mortality. We
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analyzed previously for Zimbabwe, thereby providing an unusually
high level of internal consistency. The quality and quantity of the data
have also allowed us to disaggregate the prevalence by age which, in
turn, allowed us to describe changes in HIV prevalence among young
women, an indicator of incidence in the population. This analysis
demonstrates, for the ﬁrst time, that incidence has been declining in
Harare for nearly two decades. Finally we were able to show good
agreement between the disaggregated data and the result of the
model ﬁtted to the age-pooled data, which also suggests that HIV-1
incidence has been declining steadily since the early 1990s.
The data on HIV incidence, mortality and pooled prevalence
among perinatal clinic attendees in Harare (Fig. 2) shows that
prevalence peaked at 35.9% in late 1998 and declined to 11.9% in
2009, and that mortality peaked at 1.22% in 2001/2 then began to fall
(Fig. 1). More importantly, ﬁtting a transmission model to the data
suggests that HIV-1 incidence peaked at 5.5% in 1992 and fell to 1% by
2010. The model suggests that the incidence, prevalence and
mortality will all continue to decline.
Disaggregating the prevalence data by age (Fig. 4) shows a similar
pattern across all age groups but with prevalence peaking progres-
sively later as age increases— in 1993 for the youngest age-group and
in 1999 for the oldest. Prevalence in young women has been used as a
surrogate measure of population incidence and, provided we shift the
age-speciﬁc prevalence in the youngest age group down by two years,
the time trend in the prevalence matches very closely the time trend
in incidence estimated by ﬁtting the dynamical model to the pooled
incidence, prevalence and mortality data (Fig. 5). This provides, for
the ﬁrst time, direct evidence that time trends in the prevalence of
infection in youngwomen can be used as a surrogatemeasure for time
trends in incidence with a small time delay.
Analysis of the ZVITAMBO data (Humphrey et al., 2007) demon-
strates that the decline in prevalence was independent of parental
education and occupation, maternal parity, and religious, marital,
housing and ﬁnancial status, and recruitment clinic, and not due to
differences in testing algorithms, which remained constant over the
27 months of recruitment, or laboratory errors, since 91% of positive
cases were conﬁrmed from a subsequent blood sample. Since others
have shown that, in Zimbabwe, the prevalence of HIV among
antenatal attendees is a good approximation to the prevalence
among reproductive-aged women in the general population (Gregson
et al., 2002), these declines are probably occurring among all
reproductive-aged women in Harare.
In the absence of ART, most women infected between 16 and
24 years old will die before they are 35 years old (Morgan et al., 1997).
In addition, fertility declines with age among women older than
30 years and among women infected with HIV (Terceira et al., 2003).
These factors tend to reduce the proportion of all HIV positive women
attending maternity clinics, with the greatest effect among older
women. They explain both the transient reduced proportion of older
women in the whole sample (Fig. 3) and the eventual decline in peak
prevalence (Fig. 4) in the oldest age group.What is driving the declines in HIV prevalence and incidence
in Zimbabwe?
We offer no unequivocal explanation for the dramatic, sustained
declines in HIV-1 prevalence in Zimbabwe over the past 12 years, and
in incidence for more than 15 years — greater by far than in any other
country in the region. Increased emigration, consequent on the
economic downturn at the end of the 1990s, could not have caused
the reversal of the trend in HIV incidence since this started six years
earlier. Moreover, emigration would only reduce prevalence if HIV-
positive people were more likely than HIV-negative people to
emigrate, whereas HIV prevalence among Zimbabwe women attend-ing antenatal clinics in the UK was between 9% and 11% in 2002–2004
(Gregson et al., 2010), compared to 20% at the time in Harare.
Similarly, our model for Harare indicates that behavior changes, as
a direct response to the observed rapid increases inmortality between
1990 and 2000, may explain at least part of the decline in incidence
during the 1990s but do not account for the continued decline in
prevalence after 2004(Fig. 2B).
UNAIDS estimates that in 2005 only 2% of all HIV-positive people
were on ART increasing to 19% in 2009 (UNAIDS, 2010). Since our
mortality data only extend to 2004, ART will have a negligible effect
on the mortality ﬁgures presented here. As ART becomes more
available, substantial reductions in mortality and more modest
reductions in prevalence would be expected. Our ﬁndings are
consistent with several previous studies suggesting that the observed
decline in HIV prevalence in Zimbabwe could only occur under the
assumption of declining risky sexual behavior with ensuing declines
in incidence (Gregson et al., 2010; Lopman and Gregson, 2008; Hallet
et al., 2009; Hallett et al., 2006). In support of this we note that,
although VCT and MTCT services only began in late 1999 and 2001,
respectively, education campaigns had begun so that, by 1994,
virtually all adults had heard of AIDS, 75% knew that a healthy-
looking person could be infected, more than 50% personally knew
somebody with AIDS, more than 90% knew AIDS could not be cured,
and the most commonly stated means of avoiding AIDS were given as
condom use and having only one sexual partner (Central Statistical
Ofﬁce HZ, 1995).
In this regard it may be relevant that, between 1990 and 1995, the
number of condoms distributed in the country doubled from
21.5 million to 42.7 million. By 2004 it had doubled again to
81.1 million and increased to more than 90 million by 2009 (PSI,
2004). With an estimated adult male population of about 3.6 million
the number of condoms distributed increased from 6 to 25 condoms
per adult male per year. Furthermore, the proportion of condoms sold,
rather than distributed free, rose from 1% in 1990 to 54% in 2004 and
to more than 70% in 2008 suggesting an increased awareness of the
dangers of HIV and increasing efforts to avoid them. This is consistent,
at least, with an increased awareness in the population of the dangers
of unprotected sex.
Limitations and prospects
Our analysis has two major limitations. First, our analysis included
only pregnant and post-partum women, and thus most speciﬁcally
applies to sexually active, reproductive-aged women who become
pregnant. However, ANC data are widely used for monitoring HIV
epidemics and their inference to the general population has been
carefully analyzed and discussed (Fabiani et al., 2001; Zaba et al.,
2000, 2003). Second, though the ANC surveillance system is designed
to be nationally representative, the data from the two Harare sites are
not necessarily representative of Harare. In addition, the research
studies included in this analysis were not population-based studies.
However, the single factor most likely to bias the estimated change in
prevalence is a concurrent change in age structure: this indeed did
occur, but we demonstrate substantial and signiﬁcant declines in HIV-
1 prevalence across all age groups. Finally, we acknowledge that it
would have been preferable to use mortality ﬁgures speciﬁcally for
females. Such data were not available and, in their absence, we have
minimized the dangers of any inherent bias by using only the trend in,
and not the absolute, mortality values. The important point to emerge
from the data is the timing of the peak in mortality which should be
little affected by any such bias or incompleteness in the data.
We have estimated that the annual incidence of HIV infection in
Harare peaked at about 5.5% in 1998 and fell to about 1.0% in 2008. An
annual incidence of 1% is still very high and continued diligence in
primary prevention will be essential, particularly since continued
decline cannot be assumed.
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